SEI Investments’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Other funds holding ADMA
SEI Investments's ADMA Position: Q3 2026 in Review
SEI Investments reduced its ADMA Biologics (ADMA) stake by 5.1% in Q3 2026, selling an estimated $96.4K and leaving 192,104 shares worth $1.93M. The position accounts for ﹤0.01% of the portfolio, ranked #1995.
SEI Investments first reported a position in ADMA in Q4 2022 and has held it in 16 quarters since. The position peaked at $10.9M in Q2 2025. 329 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.
- SEI Investments held 192,104 shares of ADMA Biologics worth $1.93M as of Q3 2026.
- SEI Investments sold 10,421 ADMA Biologics shares in Q3 2026, an estimated $96.4K.
- ADMA Biologics made up ﹤0.01% of SEI Investments's portfolio in Q3 2026, its #1995 holding.
- SEI Investments first reported a position in ADMA Biologics in Q4 2022 and has held it in 16 quarters since.
- SEI Investments's ADMA Biologics position peaked at $10.9M in Q2 2025.
- 329 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.
Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.